Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CASP3 | P42574 | 1/20 | 0.39 |
| ▸ | CASP2 | P42575 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17060910 | 0.85 | P4HTM (0.37) | POLBMAPTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL17060912 | 0.85 | P4HTM (0.37) | POLBMAPTKMT2AMEN1SMN1; SMN2 | |
| SCHEMBL22122715 | 0.85 | SMN1; SMN2 (0.43) | L3MBTL1SMN1; SMN2HDAC3HDAC8NCOR2 | |
| SCHEMBL22122705 | 0.84 | SMN1; SMN2 (0.41) | MAPTKMT2AMEN1L3MBTL1SMN1; SMN2 | |
| SCHEMBL22150193 | 0.82 | GAA (0.39) | POLBMAPTKMT2AMEN1L3MBTL1 | |
| SCHEMBL28544744 | 0.80 | HDAC8 (0.43) | POLBMAPTKMT2AMEN1L3MBTL1 | |
| SCHEMBL22149955 | 0.79 | SMN1; SMN2 (0.38) | MAPTKMT2AMEN1L3MBTL1SMN1; SMN2 | |
| SCHEMBL22150881 | 0.79 | GAA (0.37) | POLBMAPTKMT2AMEN1L3MBTL1 | |
| SCHEMBL22150196 | 0.78 | HDAC8 (0.39) | SMN1; SMN2HDAC3HDAC8NCOR2 | |
| SCHEMBL29391711 | 0.78 | CA1 (0.44) | POLBMAPTKMT2AMEN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240300896-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-09-12 | — | — | US | disclosed |
| US-11999696-B2 | Heterocyclic azide units and their use in polymer coatings | ILLUMINA CAMBRIDGE LIMITED (GB) | 2024-06-04 | — | — | US | disclosed |
| EP-3898586-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | Illumina Cambridge Limited (GB) | 2021-10-27 | — | — | EP | disclosed |
| US-20210284609-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-09-16 | — | — | US | disclosed |
| WO-2020126598-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | ILLUMINA CAMBRIDGE LIMITED (GB) | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300896-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | POLL, PCNA, DNMT3A | CYP1A1 2117/4885POLB 23/4885BCHE 2346/4885 |
| US-20210284609-A1 | HETEROCYCLIC AZIDE UNITS AND THEIR USE IN POLYMER COATINGS | POLL, PCNA, DNMT3A | CYP1A1 2117/4885POLB 23/4885BCHE 2346/4885 |
| US-11999696-B2 | Heterocyclic azide units and their use in polymer coatings | POLL, PCNA, DNMT3A | CYP1A1 2117/4885POLB 23/4885BCHE 2346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.